Health Sciences Acquisitions Corporation 2 (HSAQ)
Health Sciences Acquisitions Corporation 2 operates in the Shell Companies industry of the Financial Services sector, headquartered in New York City, NY, US. The stock last traded at $13.31, up 24.16% on the session, giving a market capitalisation of $149.2M. On trailing twelve-month figures it carries a trailing P/E of -16.04, a net margin of -186.3%. Its beta of 0.00 implies it has historically moved less than the broad market.
Health Sciences Acquisitions Corporation 2 currently lacks active business operations. Its primary objective is to complete a strategic business combination, such as a merger or acquisition, with one or more enterprises. These target businesses will operate within the biopharmaceutical or medical technology sectors and be located in North America or Europe. The company was established in 2020 and is headquartered in New York, New York.
Health Sciences Acquisitions Corporation 2 is most often compared with the following Financial Services names: